Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Jeffrey Scott, MD, explains his vision for how GPOs must evolve in the era of value-based care

Jeffrey Scott, MD, Chief Medical Officer, IntegraConnect, explains his vision for how GPOs must evolve in the era of value-based care

Published: 10 February 2017

Recent Videos: Business (includes M&A, Licensing, Legal, Venture Capital, and Marketing)

There have been no new videos in this category within the last 12 months.

Related Videos

video-image

Jeffrey Scott, MD, discusses best practices for a GPO to help with value-based savings

video-image

Stephen Schleicher, MD, MBA, discusses participation in the Oncology Care Model

video-image

Adam P. Dicker MD, PhD, FASTRO, considers the challenges associated with value-based cancer care

video-image

Adam P. Dicker MD, PhD, FASTRO, on how technology is positively impacting cancer care

video-image

Adam P. Dicker MD, PhD, FASTRO, on embracing digital health

video-image

Adam P. Dicker MD, PhD, FASTRO, on how technology is transforming the delivery of cancer services

video-image

Brad Prechtl tell us why practices should consider joining American Oncology Network

video-image

Brad Prechtl offers his opinion on what oncology practices need to thrive

video-image

Brad Prechtl considers how oncology practices are evolving to survive in today’s environment

video-image

Alexander Spira, MD, PhD, FACP, tells us the latest thinking regarding the PD-L1 biomarker

video-image

Russell Gollard, MD, offers opinion on why IDNs are a cancer delivery model of the future

video-image

Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

video-image

Russell Gollard, MD, considers the difference between a hospital and a non-hospital IDN

video-image

Alexander Spira, MD, PhD, FACP, on the recent approval of atezolizumab in SCLC

video-image

Russell Gollard, MD, considers the main impediments to coordinated care

video-image

Alexander Spira, MD, PhD, FACP, on how Virginia Cancer Specialists is embracing value-based care

video-image

Russell Gollard, MD, explains how IDNs effectively coordinate cancer care

video-image

Russell Gollard, MD, elaborates on OptumCare's provider model

video-image

Joe Flower offers opinion on bundled payments and the economics of cancer care

video-image

Joe Flower regarding the evolution of the fee-for-service model

video-image

Joe Flower speculates on how large buyers of healthcare may shape access to services

video-image

Andrew Hertler, MD, FACP, on measuring success in value-based cancer care delivery

video-image

Andrew Hertler, MD, FACP, offers advice to oncology practices entering the value-based world

video-image

Andrew Hertler, MD, FACP, considers the benefits of participating in an ACO

video-image

Michelle Settelmyer on how nurses are becoming more involved in genetic counseling & testing

video-image

Andrew Hertler, MD, FACP, explains the benefits of integrated delivery networks (IDNs)

video-image

Michelle Settelmyer regarding the benefits of providing cancer screening & genetic counseling

video-image

Feyi Olopade Ayodele explains the need for software to run risk assessment programs

video-image

Michelle Settelmyer on the challenges of bringing cancer screening to community cancer centers

video-image

Feyi Olopade Ayodele considers the financial benefits of adopting a genetic screening program

video-image

Erich Mounce tells us how technology is enhancing oncology care today

video-image

Todd Schonherz explains what AON has to offer physicians and their practices

video-image

Erich Mounce shares how OneOncology is providing value in cancer care delivery

video-image

Todd Schonherz on how American Oncology Network differs from other practice models

video-image

Erich Mounce considers how OneOncology differs from other practice models

video-image

Todd Schonherz on the formation of the American Oncology Network (AON)

video-image

Erich Mounce elaborates on the NexGen oncology practice model

video-image

Benjamin Paz, MD, outlines the role of surgery in cancer treatment

video-image

Benjamin Paz, MD, on measuring success when teams coordinate surgery, radiation & medical oncology

video-image

Joanie Mayer Hope, MD, regarding Any Mountain's fight against ovarian cancer

video-image

Benjamin Paz, MD, regarding the coordination of surgical cancer services

video-image

Joanie Mayer Hope, MD, regarding the core message of Any Mountain

video-image

Allen Lichter, MD, offers opinion on value-based cancer care

video-image

Joanie Mayer Hope, MD, on how Any Mountain is supporting women with ovarian cancer

video-image

Allen Lichter, MD, elaborates on reimbursement and direct buying

video-image

Michael Kolodziej, MD, considers value-based care & fee-for-service models

video-image

Allen Lichter, MD, considers the impact of high drug prices on oncology practices

video-image

Michael Kolodziej, MD, offers his opinion on payment reform

video-image

Allen Lichter, MD, on artificial intelligence, predictive analytics and telehealth

video-image

Michael Kolodziej, MD, elaborates on bundled payments and the economics of cancer care

video-image

Allen Lichter, MD, considers some major trends influencing cancer services

video-image

Michael Kolodziej, MD, considers efficiency and productivity in oncology care today

video-image

Tom Gallo shares how ACCC is encouraging resilience in oncology teams

video-image

Amy Ellis on how AI has brought about a better understanding of the whole cancer patient

video-image

Tom Gallo considers whether oncology team burnout extends beyond physicians

video-image

Amy Ellis describes the hurdles introduced by artificial intelligence

video-image

Tom Gallo shares how ACCC is addressing oncology team burnout

video-image

Amy Ellis regarding artificial intelligence and value-based cancer care

video-image

Crystal Dugger, MBA, RN, BSN, on the role of technology in establishing a nurse navigation program

video-image

Amy Ellis considers how artificial intelligence is being applied to cancer care

video-image

Crystal Dugger, MBA, RN, BSN, describes the value of nurse navigation programs

video-image

Teri Bedard regarding the implications of coding mistakes

video-image

Crystal Dugger, MBA, RN, BSN, on how nurse navigation programs help patients & hospital networks

video-image

Teri Bedard elaborates on common coding mistakes

video-image

Chadi Nabhan, MD, MBA, regarding the risks related to two-sided payment agreements

video-image

Chadi Nabhan, MD, MBA, elaborates on the skepticism regarding MACRA

video-image

Ted Okon, MBA, speculates on the path forward regarding 340B policy

video-image

Ted Okon, MBA, on the impact of the reduction in reimbursement for hospitals participating in 340B

video-image

Jeff Mortier speculates on the future of 340B policy

video-image

Jeff Mortier considers how 340B is impacting community oncology

video-image

Fred Schnell, MD, explains what COA is doing to help practices succeed in the OCM

video-image

Suanne Gersdorf, FACHE, MSB, shares how 340B has impacted her practice

video-image

Melissa Johnson, MD, on how Next Generation Sequencing is relevant to the treatment of NSCLC

video-image

Jennie Crews, MD, MMM, FACP, on the influence of MIPS & MACRA at Seattle Cancer Care Alliance

video-image

Carrie Tompkins Stricker, PhD, RN, AOCN, on the importance of capturing all patient symptoms

video-image

Carrie Tompkins Stricker, PhD, RN, AOCN, on what Carevive is doing to encourage patient engagement

video-image

Carrie Tompkins Stricker, PhD, RN, AOCN, on the outcomes of patients engaged in their treatment

video-image

Carrie Tompkins Stricker, PhD, RN, AOCN, speaks to the importance of patient engagement

video-image

Carrie Tompkins Stricker, PhD, RN, AOCN, on the contribution of patient reported outcomes

video-image

Pamela Tobias, MS, RHIA, CHDA, on whether LVHN is utilizing predictive analytics

video-image

Pamela Tobias, MS, RHIA, CHDA, on oncology-specific EMRs & standardization of treatment plans

video-image

Pamela Tobias, MS, RHIA, CHDA, explains how EHRs can help maximize utilization of resources

video-image

Pamela Tobias, MS, RHIA, CHDA, regarding EHR data & the impact on quality and/or cost outcomes

video-image

Pamela Tobias, MS, RHIA, CHDA, offers examples of how EHRs are improving practice processes

video-image

Pamela Tobias, MS, RHIA, CHDA, considers whether EHRs are making practices more efficient

video-image

Mark Soberman, MD, MBA, FACS, on what we can learn from the 2018 ACCC Annual Meeting

video-image

Mark Soberman, MD, MBA, FACS, tells us about his goals going into the 2018 ACCC Annual Meeting

video-image

Mark Soberman, MD, MBA, FACS, speculates on the future of cost-effective, high-quality cancer care

video-image

Mark Soberman, MD, MBA, FACS, regarding innovative oncology payment models

video-image

Mark Soberman, MD, MBA, FACS, considers next generation multidisciplinary cancer care

video-image

Mark Soberman, MD, MBA, FACS, provides examples of the benefits of coordinated care

video-image

Mark Soberman, MD, MBA, FACS, on the importance of coordinated care & multidisciplinary care

video-image

Satish Shah, MD, considers the process of getting physicians in his practice to adopt the EHR

video-image

Satish Shah, MD, on how technology can ease the burden of reporting quality measures

video-image

Satish Shah, MD, regarding the important features that every oncologist should have in their EHR

video-image

Satish Shah, MD, provides examples of how EHRs are improving practice processes

video-image

Michael Seiden, MD, PhD, on the tools MSH provides to member practices to help them thrive

video-image

Michael Seiden, MD, PhD, tells us how big data is helping to advanced clinical progress

video-image

Michael Seiden, MD, PhD, regarding the workforce shortage in oncology

video-image

Michael Seiden, MD, PhD, provides opinion on innovative oncology payment models

video-image

Michael Seiden, MD, PhD, considers the problems MSH are trying to solve for oncologists

video-image

Git Patel considers how real-time symptom management can improve adherence

video-image

Git Patel analyzes the adherence problem and tools available to help solve the issue

video-image

Git Patel regarding the importance of Chronic Care Management

video-image

Git Patel explains how technology can help practices acquire more revenue

video-image

Kavita Patel, MD, MS, FACP, discusses how 340B has impacted her practice

video-image

Kavita Patel, MD, MS, FACP, regarding the impact of MACRA on payment reform

video-image

Kavita Patel, MD, MS, FACP, speculates on next generation multidisciplinary cancer care

video-image

Kavita Patel, MD, MS, FACP, provides examples of the advantages of coordinated care

video-image

Kavita Patel, MD, MS, FACP, tells us why oncologists should coordinate care

video-image

Stephen Grubbs, MD, discusses how we measure quality cancer care today

video-image

Stephen Grubbs, MD, tells us how genomics are figuring into the value-based care equation

video-image

Stephen Grubbs, MD, speculates on the future of cost-effective cancer care

video-image

Stephen Grubbs, MD, regarding value assessment tools and treatment decisions

video-image

Stephen Grubbs, MD, considers how MIPS & MACRA are transforming the delivery of cancer care

video-image

Stephen Grubbs, MD, describes the tools ASCO provides to help practices move toward value-based care

video-image

Stephen Grubbs, MD, on what ASCO is doing to help educate members about MIPS & MACRA

video-image

Bobby Green, MD, analyzes the role of health technology companies in the design of APMs

video-image

Bobby Green, MD, shares how big data can make a positive contribution to payment reform

video-image

Bobby Green, MD, regarding big data and clinical progress

video-image

Bobby Green, MD, describes how EMR data becomes real world evidence

video-image

Ann Marie Edwards on how patients have been impacted by value-based care

video-image

Ann Marie Edwards tells us how technology has impacted the delivery of value-based care

video-image

Ann Marie Edwards examines how 340B has impacted Alliance Cancer Specialists

video-image

Ann Marie Edwards offers opinion on how to thrive in today’s oncology landscape

video-image

Ann Marie Edwards considers the physician practice models poised to succeed in a value-based world

video-image

George Daneker, MD, on the role of CMS and commercial payers in delivering value-based care

video-image

George Daneker, MD, offers opinion on various cancer care models

video-image

George Daneker, MD, regarding the role of consistency in the delivery of high-quality care

video-image

George Daneker, MD, on the advantages of having all medical oncology services under one roof

video-image

Jennie Crews, MD, MMM, FACP, on embracing new value-based oncology models

video-image

Jennie Crews, MD, MMM, FACP, explains how to maintain the delivery of quality cancer care

video-image

Sibel Blau, MD, discusses how 340B has impacted Northwest Medical Specialties

video-image

Sibel Blau, MD, shares how her practice has transformed in order to participate in MACRA

video-image

Sibel Blau, MD, regarding NWMS's affiliation with the Quality Cancer Care Alliance

video-image

Sibel Blau, MD, on the possibility of consolidating or merging her practice

video-image

Sibel Blau, MD, explains how her practice has adapted to the value-based world of medical oncology

video-image

Roy Beveridge, MD, offers examples of successful & unsuccessful cancer intervention methods

video-image

Roy Beveridge, MD, considers the social determinants influencing outcomes in cancer care

video-image

Roy Beveridge, MD, tells us how interoperability is impacting the delivery of cancer care

video-image

Roy Beveridge, MD, explains how Humana works with cancer stakeholders to develop treatment models

video-image

Roy Beveridge, MD, offers opinion on the evolution of commercial payers

video-image

Roy Beveridge, MD, regarding the most cost-efficient alternative payment models

video-image

Roy Beveridge, MD, on the scale of cancer treatment management at Humana

video-image

Jamie Bachman, MPA, elaborates on the issue of compatibility and oncology-specific EHRs

video-image

Jamie Bachman, MPA, on how integrating various software into EHRs improves processes

video-image

Jamie Bachman, MPA, regarding important features that every oncologist should have in their EHR

video-image

Jamie Bachman, MPA, on the potential drawbacks associated with oncology-specific EHRs

video-image

Jamie Bachman, MPA, offers examples of how EHRs are allowing practices to improve processes

video-image

Jamie Bachman, MPA, considers whether EHRs are making practices more efficient

video-image

Patricia Goldsmith shares what CancerCare is doing to help patients with financial toxicity

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, speculates on the cost implications of abiraterone

video-image

Randall Oyer, MD, describes how ACCC is supporting practices that are participating in OCM

video-image

Randall Oyer, MD, reveals the challenges and solutions his practice is finding as a result of OCM

video-image

Randall Oyer, MD, shares major themes emerging from the OCM

video-image

Randall Oyer, MD, on how OCM is helping the healthcare system transition from volume to value

video-image

Leonard Saltz, MD, elaborates on what interventions could help alleviate financial toxicity

video-image

Leonard Saltz, MD, on how to begin the conversation with patients about financial toxicity

video-image

Andrew Pecora, MD, FACP, CPE, on the implications of healthcare and reimbursement reform

video-image

Andrew Pecora, MD, FACP, CPE, describes the movement to value-based reimbursement

video-image

Andrew Pecora, MD, FACP, CPE, on healthcare reform and the move from volume to value in oncology

video-image

Debra Patt, MD, MPH, MBA, speculates on upcoming changes in the 340B program

video-image

Lucio Gordan, MD, shares his concerns with PBMs as they affect community oncology practices

video-image

David Eagle, MD, shares how his small practice is successful in today’s oncology environment

video-image

David Eagle, MD, compares the rate of oncology spending to rate of total healthcare spending

video-image

David Eagle, MD, evaluates what part of total oncology care spending is drug spending

video-image

Joseph Lynch, MD, on why independent community oncology practices join hospital systems

video-image

Skip Burris, MD, shares how clinical pathways impact prescribing decisions

video-image

Skip Burris, MD, on the impact of OCM on large community practices

video-image

Bruce Feinberg, DO, on what community oncologists should consider with MACRA, MIP’s and OCM

video-image

Jeff Patton, MD, shares how clinical pathways help with value-based efforts

video-image

Jeff Patton, MD, on whether the Oncology Care Model impacts the prescribing of oral cancer agents

video-image

Jeff Patton, MD, explains how Tennessee Oncology has transformed to participate in OCM

video-image

Lucio Gordan, MD, considers how 340B is impacting physicians and practices

video-image

Robert Baird Jr. reflects on how his practice has changed as a result of OCM

video-image

Edward Li on how clinical pathways are making progress towards their original goals

video-image

Edward Li reflects on how pathways have impacted oncology treatment over the last 5 years

video-image

Ted Okon lists key takeaways from the 2017 COA meeting

video-image

Ted Okon describes how PBMs affect oncologists and cancer patients

video-image

Ted Okon shares the latest news on the 340B policy

video-image

Ben Jones gives advice to practices interested in advocating for community oncology

video-image

Lalan Wilfong, MD, shares lessons from his experience participating in OCM

video-image

Lalan Wilfong, MD, explains how OCM has impacted cancer patients in his practice

video-image

Lalan Wilfong, MD, provides opinion on how OCM is changing his practice

video-image

Debra Patt, MD, considers how community oncology contributes to clinical research advancement

video-image

Debra Patt, MD, on technological advances in cancer care and community oncology

video-image

Debra Patt, MD, shares how community oncology has contributed to advances in population health

video-image

Debra Patt, MD, elaborates on how community oncology contributes to the Cancer Moonshot

video-image

Jeff Vacirca, MD, shares how COA is addressing the DIR fees coming from PBMs

video-image

Jeff Vacirca, MD, on COA’s efforts to represent community oncologists

video-image

Jeff Vacirca, MD, discusses DIR fees and how COA hopes to solve the PBM fee problem

video-image

Jeff Vacirca, MD, on how COA is addressing Part B concerns among community oncologists

video-image

Lucio Gordan, MD, on how community oncology practices can utilize their own data

video-image

Lucio Gordan, MD, reflects on how he sees community oncology using big data

video-image

Matt Farber provides insight on the evolution of specialty pharmacies

video-image

Matt Farber explains the role of specialty pharmacy in delivering quality cancer care

video-image

David Eagle, MD, compares small, community oncology practices with large practices and hospitals

video-image

Ray Bailey on how participation in OCM impacts the in-house pharmacy at FCS

video-image

Patrick Cobb, MD, on cancer care costs in hospital outpatient and community settings

video-image

Brad Prechtl offers his opinion on how size influences community oncology practices

video-image

William Harwin, MD, on how clinical pathways impact treatment decisions at FCS

video-image

William Harwin, MD, explains how he manages the quality measures required for OCM

video-image

William Harwin, MD, on working with local payers to deliver quality care

video-image

William Harwin, MD, talks changes at Florida Cancer Specialists since participating in OCM

video-image

Barbara McAneny, MD, discusses 1 sided and 2 sided risk associated with participation in the OCM

video-image

Barbara McAneny, MD, shares her concerns with the way OCM is progressing at this point

video-image

Ricky Newton tells us how COA is addressing the PBM DIR fees and helping community oncology

video-image

Bobby Green, MD, on how oncologists can leverage data to understand real quality care

video-image

Barbara McAneny, MD, explains how the AMA and community oncology should interact

video-image

Ana Aparicio, MD, on immunotherapy as a future treatment guideline for metastatic prostate cancer

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, on immunotherapy and metastatic prostate cancer

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, on BRCA1 and BRCA2 genetic testing as guidelines

video-image

Charles Saunders, MD, on the operational changes necessary to succeed in a value-based environment

video-image

Charles Saunders, MD, considers EHR providers in an era of value-based care

video-image

Charles Saunders, MD, discusses how value-based care is driving technology innovation in oncology

video-image

Neal D. Shore, MD, FACS, on BRCA1 and BRCA2 genetic testing as guidelines for prostate cancer

video-image

Maddy Herzfeld, discusses the challenges practices are facing when implementing patient engagement

video-image

Maddy Herzfeld, on solutions available for practices to implement better patient engagement

video-image

Maddy Herzfeld, on how oncology practices consume patient-reported data to improve patient care

video-image

Marcus Neubauer, MD, explains how clinical pathways save money when treating cancer

video-image

Marcus Neubauer, MD, discusses if clinical pathways create value in cancer care

video-image

Marcus Neubauer, MD, explains how clinical pathways differ from clinical guidelines

video-image

Marcus Neubauer, MD, discusses how practices and administrators can build higher pathway compliance

video-image

Mike Kolodziej, MD, explains the impact of the ACA on the insurance industry

video-image

Mike Kolodziej, MD, talks about how CMMI is changing the health care system

video-image

Mike Kolodziej, MD, discusses how technology is helping reform the way practices operate

video-image

Mike Kolodziej, MD, on how the clinical data set at Flatiron helps oncologists

video-image

Mike Kolodziej, MD, explains how Flatiron analytics help practices succeed in value based care

video-image

Jonathan Hirsch, President and Founder, Syapse, on the value of sharing patient-specific information

video-image

Jonathan Hirsch, discusses how precision medicine is being used to help improve cancer treatment

video-image

Jonathan Hirsch, on precision medicine software helping oncologists make therapeutic decisions

video-image

Ira Klein, MD, on what the shift toward oral oncolytics means for the supply chain

video-image

Ed Bassin, Ph.D., on what oncologists should be thinking about as they approach value based care

video-image

Ed Bassin, Ph.D., on working with hospital-based cancer centers vs community practices

video-image

Ed Bassin, Ph.D., on if there will be health care savings with the implementation of the OCM

video-image

Ed Bassin, Ph.D., explains the challenges for oncologists and practices with the OCM model

video-image

Ira Klein, MD, explains how risk management changes the way we manage supply chain

video-image

Ira Klein, MD, discusses how limited distribution impacts the delivery of oral cancer agents

video-image

Diana Verrilli, McKesson Specialty Health, on how claims data is being used

video-image

Diana Verrilli, McKesson Specialty Health, on how claims data can be used in the OCM model

video-image

Steve D’Amato, R.Ph., talks about data capture and data analytics at New England Cancer Specialists

video-image

Steve D’Amato, R.Ph., talks about what technology his practice adopted to participate in OCM

video-image

Steve D’Amato, R.Ph., on why this is a challenging time for oncology practices

video-image

Steve D’Amato, R.Ph., explains how his practice helps patients get access to cancer care

video-image

Steve D’Amato, R.Ph., on whether the ACA changed access to care at New England Cancer Specialists

video-image

Jeffrey Scott, MD, shares the highest-impact areas of focus for value-based care savings

video-image

Jeffrey Scott, MD, on how important the drug channel is compared to reduction in hospitalizations

video-image

Bobby Green, MD, on using genomic data to prescreen eligibility for clinical trials

video-image

Bobby Green, MD, discusses collaboration efforts between Flatiron and Foundation Medicine

video-image

Bobby Green, MD, on leveraging genomic testing into actionable data

video-image

Dave Terry, Chief Executive Officer, on the keys to success when participating in APMs

video-image

Dave Terry, Chief Executive Officer, shares his thoughts on Alternative Payment Models of the future

video-image

Dave Terry, Chief Executive Officer, explains why practices should participate in APMs

video-image

James Hamrick, MD, shares his thoughts on how we are evolving toward a learning health care system

video-image

Debra Patt, MD, on what tele-health brings to cancer care

video-image

Debra Patt, MD, explains how data systems help with patient care delivery in community oncology

video-image

Linda Bosserman, MD, explains what MACRA means for oncologists today

video-image

Linda Bosserman, MD, discusses the highlights of the MACRA panel at CCBS 2017

video-image

Lili Brillstein, M.P.H., explains the primary goal of an episode of care

video-image

Lili Brillstein, M.P.H., explains how an episode of care is different from a bundled payment

video-image

Harlan Levine, MD, tells us about the continuous cycle of learning and improving at City of Hope

video-image

Harlan Levine, MD, on the philosophy for establishing quality metrics as they relate to an ACO

video-image

James Hamrick, MD, on using real world evidence to learn how to treat cancer patients

video-image

Lili Brillstein, M.P.H., shares her thoughts on the keys to success to make episodes of care work

video-image

Lili Brillstein, M.P.H., explains the requirements that must be met in an episode assessment

video-image

Harlan Levine, MD, on treating patients in this era of high cost cancer drugs

video-image

Harlan Levine, MD, on how cancer care navigators impact quality of care at City of Hope

video-image

James Hamrick, MD, explains how EMRs help connect patients and caregivers

video-image

Debra Patt, MD, explains how decision support tools improve the quality and delivery of cancer care

video-image

Debra Patt, MD, explains using predictive analytics to improve cancer care delivery

video-image

Linda Bosserman, MD, explains “Pick Your Pace” as it relates to participation in MACRA

video-image

Linda Bosserman, MD, on deciding whether to participate in MIPS or AAPM

video-image

Alan P. Venook, MD, explains how the 80405 study and its impact on treatment guidelines

video-image

Chadi Nabhan, MD, on payers using clinical pathways in hematological malignancies vs solid tumors

video-image

Chadi Nabhan, MD, on incorporating clinical pathways into CLL and other hematologic malignancies

video-image

Charles Bane, MD, touches on the COME HOME project while discussing the Oncology Care Model

video-image

Charles Bane, MD, touches on the COME HOME project while discussing the Oncology Care Model

video-image

Charles Bane, MD, discusses the practicality of the value tool at Dayton Physicians Network

video-image

Perspective on the NCCN Evidence Blocks by Charles Bane, MD

video-image

Perspective on the ASCO Value Framework by Charles Bane, MD

video-image

Bruce Gould, MD, explains how the value tools could be used in the community practice setting

video-image

Perspective on the NCCN Evidence Blocks provided by Bruce Gould, MD

video-image

Perspective on the ASCO Value Framework provided by Bruce Gould, MD

video-image

Bruce Gould, MD, explains ASCO’s policy toward clinical pathways at this time

video-image

The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD

video-image

Bruce Gould, MD, describes the concerns his practice has with clinical pathways

video-image

Barbara McAneny, MD, explains why CMS implemented the ASP experiment

video-image

Barbara McAneny, MD, informs as to what practices should know about MACRA

video-image

Barbara McAneny, MD, reviews the COME HOME project’s influence on the Oncology Care Model

video-image

Barbara McAneny, MD, discusses COME HOME’s adaptability to other community oncology practices

video-image

Barbara McAneny, MD, talks about the COME HOME project’s impact on community oncology practices

video-image

Barbara McAneny, MD, discusses the COME HOME project’s future

video-image

Jeff Patton, MD, explains what could happen if the CMS ASP Experiment proceeds as planned by CMS

video-image

Jeff Patton, MD, explains how Tennessee Oncology benefits from being a member of COA

video-image

Jeff Patton, MD, explains why the 2016 COA meeting is a must attend meeting

video-image

Jeff Patton, MD, discusses his new role with the Community Oncology Alliance (COA)

video-image

Deborah Patt, MD, shares her concerns about the CMS ASP Experiment and Part B reimbursement

video-image

Deborah Patt, MD, tells us how chemotherapy costs figure into total care

video-image

Deborah Patt, MD, points out how oncologists can reduce cancer costs

video-image

Deborah Patt, MD, details surprising outcomes from a recent cost study

video-image

Deborah Patt, MD, looks at the bigger expense drivers in cancer care

video-image

David Eagle, MD, gives his opinion on the CMS ASP Experiment

video-image

David Eagle, MD, enumerates what oncologists can do to bring cancer costs down

video-image

David Eagle, MD, lists outcomes from the COA study surprising to oncologists

video-image

David Eagle, MD, details the bigger expenses driving up cancer care costs based on the COA study

video-image

David Eagle, MD, compares costs for treating cancer vs. non-cancer based on the COA study

video-image

David Eagle, MD, talks about COA’s Cost Drivers of Cancer Care study

video-image

Bhuvana Sagar, MD, tells us about the Cigna medical home for oncologists

video-image

Bhuvana Sagar, MD, discusses Cigna’s work with oncologists to find alternative payment models

video-image

Bhuvana Sagar, MD, explains the need for alternative payment models in oncology

video-image

Barry Russo explains the impact of the CMS ASP Experiment

video-image

Practices need to get ready to replace buy and bill explains Barry Russo

video-image

Bruce Gould, MD, explains the characteristics that makes a practice ready for OCM

video-image

Brad Prechtl briefs us on his concerns with the“Medicare Experiment” and its impact

video-image

Brad Prechtl tells how his practice is working to improve cancer care

video-image

Brad Prechtl talks about how community oncology practices can survive today

video-image

Brad Prechtl explains the benefits of community oncology practices joining forces

video-image

Bhuvana Sagar, MD, forecasts the possible Cigna adoption of a Medicare OCM model

video-image

Participation in the Oncology Care Model (OCM) as explained by Barry Russo

video-image

Barry Russo explains how important it is to embrace alternative payment models

video-image

Barry Russo tells us how his practice is getting ready for value-based care

video-image

Patrick Cobb, MD, FACP, looks ahead to treatment innovations that will make a difference

video-image

Patrick Cobb, MD, FACP, talks about some exciting, recent innovations in cancer treatment

video-image

Michael Diaz, MD, talks about working with payers to add quality and value

video-image

Michael Diaz, MD, discusses the challenges in adopting quality and value measures

video-image

Michael Diaz, MD, talks about why the community oncology setting is the best value for patients

video-image

John Fox, MD, predicts if the ASCO Value Framework or NCCN Evidence Blocks will impact drug spend

video-image

John Fox, MD, talks about how Priority might use the ASCO and NCCN value tools

video-image

John Fox, MD, talks about the new value tools from ASCO and NCCN

video-image

John Fox, MD, provides perspective on collaborating with providers on clinical pathways

video-image

A look at cancer clinical pathways with Charles Bane, MD

video-image

Ricky Newton, CPA, updates us on COPA

video-image

Ricky Newton, CPA, details how COPA’s website helps practice managers, pharmacists, and patients

video-image

Ricky Newton, CPA, explains the purpose of COPA’s new In-House and Specialty Pharmacies brief

video-image

Ricky Newton, CPA, tells us what follow up to expect from COPA’s new brief

video-image

Robert Baird fills us in on the Value-Based Purchasing Modifier's impact on Dayton

video-image

Robert Baird details how practices can prepare for the Value-Based Purchasing Modifier and MIPS

video-image

Robert Baird explains how Dayton physicians and payers are collaborating on APMs

video-image

Robert Baird answers questions on Dayton’s participation in the Oncology Care Model

video-image

Skip Burris, MD, outlines the scope of cancer clinical trials at SCRI

video-image

Skip Burris, MD, looks at the promise of immunotherapies in combination

video-image

Skip Burris, MD, explains goals and outcomes of the My Pathway trial

video-image

Skip Burris, MD, reflects on the promise and concerns with liquid biopsies

video-image

Ted Okon tells us why the CNS ASP Experiment is a bad idea

video-image

Embrace alternative payment models explains Ted Okon

video-image

Todd Murphree, PharmD, tells us how in-house dispensing in his practice benefits patients

video-image

Todd Murphree, PharmD, tells us how in-house dispensing in his practice benefits patients

video-image

Todd Murphree, PharmD, explains the role an in-house pharmacy plays in the quality equation

video-image

Sue Naeyaert predicts whether we will see more cancer biosimilars soon

video-image

Sue Naeyaert tells us what to expect in pricing biosimilars

video-image

A look at the expansion of a biosimilar’s FDA label with Sue Naeyaert

video-image

Sue Naeyaert explains the proposed reimbursement of biosimilars by CMS

video-image

Skip Burris, MD, discusses how precision medicine is changing cancer treatment

video-image

Sue Naeyaert provides her vision of the biosimilar products in development

video-image

Todd Murphree briefs us on ACHC’s oncology accreditation process

video-image

Todd Murphree, PharmD, discusses how ACHC accreditation benefits his practice

video-image

Ted Okon discusses the sessions that stand out at this year's annual meeting

video-image

Ted Okon discusses the 2016 Community Oncology Alliance annual meeting

video-image

Ted Okon discusses the 2016 Community Oncology Alliance annual meeting

video-image

Ted Okon provides an overview of the Cost Drivers in Cancer Care study

video-image

Mary Kruczynski speaks to those who were unable to attend the 2016 Annual COA meeting

video-image

Mary Kruczynski tells us how the 2016 Annual COA meeting benefits health care providers

video-image

Mary Kruczynski reflects on highlights from COA

video-image

Lucio Gordan, MD, lists takeaways from COA that can benefit his own practice

video-image

Lucio Gordan, MD, debriefs providers who didn’t attend on highlights from COA

video-image

Lucio Gordan, MD, reflects on key messages from this year’s COA

video-image

Jeff Vacirca, MD, explains the relevance of the COA/Milliman study to his practice

video-image

Jeff Vacirca, MD, talks about what his community oncology practice is doing to survive

video-image

Jeff Patton, MD, explains how his practice is working to develop alternative payment models

video-image

COA is helping community oncologists by fighting the CMS ASP Experiment by Jeff Patton, MD

video-image

Gary Palmer, MD, JD, MBA, describes the clinical utility of the GPS Cancer test

video-image

Gary Palmer, MD, JD, MBA, tells us about the mission of NantWorks and NantHealth

video-image

Gary Palmer, MD, JD, MBA, discusses how precision medicine figures into cancer treatment algorithms

video-image

John Iacuone, MD, MBA, explains what capital improvements and services VCCN provides to oncologists

video-image

John Iacuone, MD, MBA, explains how practices stay independent in pay for performance environment

video-image

John Iacuone, MD, MBA, discusses the economic advantage for oncologists that join the VCCN

video-image

John Iacuone, MD, MBA, explains why Vantage Cancer Care Network was created and their mission

video-image

Kavita Patel, MD, MS discusses how important cancer care management is to Medicare

video-image

Kavita Patel, MD, MS, explains how 340B is impacting cancer care

video-image

Kavite Patel, MD, MS, tells us whether ACOs are having an impact on oncologists

video-image

Kavita Patel, MD, MS, describes the Triple Aim

video-image

Linda Bosserman, MD, discusses the challenges with the rise in consumerism and patient integration

video-image

Linda Bosserman, MD, explains how her practice implemented structural data collection in an EMR

video-image

Linda Bosserman, MD, explains how her private practice served two Safety Net hospitals in her region

video-image

Madelyn Trupkin Herzfeld discuses how cancer patients are involved in treatment decision-making

video-image

Madelyn Trupkin Herzfeld defines patient engagement, and the tools patients use with their care team

video-image

Madelyn Trupkin Herzfeld explains what does Carevive does to help patients with cancer

video-image

Michael Kolodziej, MD, discusses alternative payment models of the future

video-image

Michael Kolodziej, MD, describes the breadth and depth of alternative payment models

video-image

Michael Kolodziej, MD, tells us why alternative payment models are needed

video-image

William Harwin, MD, tells us what smaller practices can learn from his experience

video-image

William Harwin, MD, explains how quality measures are being integrated into his practice

video-image

William Harwin, MD, tells us about the ancillary services his pracdtice has to help patients

video-image

William Harwin, MD, gives his opinion if practices can survive in today's value based environment

video-image

David Lansky gives the employer perspective on quality cancer care

video-image

David Lansky has ideas on how patient reported data can be captured

video-image

David Lansky describes how patient reported outcomes can measure of health care system improvement

video-image

David Lansky explains how can we improve efficiency in the health care system

video-image

Bobby Green, MD, MSCE, discusses Flatiron’s approach to tackling today's value issues

video-image

Bobby Green, MD, MSCE, discusses how we use these data to drive quality

video-image

Bobby Green, MD, MSCE, tells us which data is needed to curate a complete picture of the patient

video-image

Bobby Green, MD, MSCE, explains the frustrations with data coming from oncology practices

video-image

Debra Patt, MD, discusses what the future holds for quality improvement in oncology

video-image

Debra Patt, MD, explains what some of the limitations of quality improvement measurements are

video-image

Debra Patt, MD, tells us the history of quality improvement

video-image

Charles Rosen, MD, discusses avoidable costs in cancer care

video-image

Charles Rosen, MD, explains how team care is important to improving cancer care

video-image

Charles Rosen, MD, discusses the future of specialty care nationally

video-image

Andrew Schorr explains how his story represents a change in the patient and doctor relationship

video-image

Andrew Schorr tells us the information and resources that patients want out of cancer websites

video-image

Andrew Schorr tells us his story as a 2-time cancer survivor

video-image

Robert Baird tells us what MIPS are and how practices might use them

video-image

Patrick Cobb, MD, discusses treatment innovations and managing patient’s expectations

video-image

Jeff Vacirca, MD, shares his thoughts on the “Medicare Experiment” on community oncology

video-image

David Eagle, MD, compares treatment costs in different settings

video-image

Mary Kruczynski tells us how the Cost Drivers in Cancer Care study was developed

video-image

Patrick Soon-Shiong, MD, FRCS(C), FACS, discusses the Cancer Moonshot

video-image

Patrick Soon-Shiong, MD, tells us why it is important to target the tumor microenvironment

video-image

Patrick Soon-Shiong, MD, FRCS(C), FACS, describe the GPS Cancer test

video-image

Patrick Soon-Shiong, MD, FRCS(C), FACS, explains why have we not won the war on cancer

video-image

John Sprandio, MD explains why practices need analytics in an alternative payment model

video-image

John Sprandio, MD discusses why his practice partnered with Vantage Cancer Care Network

video-image

John Sprandio, MD explains why oncologists should practice in an IPA model

video-image

John Sprandio, MD, tells us about the economic reality of an oncology medical home

video-image

John Sprandio, MD, discusses how patient-centered oncology medical homes impacted on ER visits

video-image

John Sprandio, MD, discusses the degree services drive the likelihood of achieving clinical outcomes

video-image

John Sprandio, MD, explains how his practice worked with Capital Blue Cross

video-image

John Sprandio, MD, explains how his practice worked with CMS to help develop the Oncology Care Model

video-image

John Sprandio, MD, discusses the changes his practice made to become a patient centered medical home

video-image

Jennifer Carter, MD, explains how N-of-One uses precision medicine to recommend treatment strategies

video-image

Jennifer Carter, MD, MPH, explains how oncology clinical trial design is adopting precision medicine

video-image

Jennifer Carter, MD, MPH, tells us the biggest challenges facing adoption of precision medicine

video-image

Jennifer Carter, MD, MPH, explains how hospital systems can launch a precision medicine program

video-image

Jennifer Carter, MD, MPH, describes how precision medicine can change the way cancer is treated

video-image

Ira Klein, MD, MBA, FACP, discusses the challenges as we move to a more risk bearing environment

video-image

Ira Klein, MD, MBA, FACP, explains how oncologists can support their primary care colleagues

video-image

Ira Klein, MD, MBA, FACP, discusses if oncology has a meaningful role to play in population health

video-image

Harold Miller explains what types of payment models hold the most promise for oncologists

video-image

Harold Miller discusses PCOP and how it would decrease spending on cancer care

video-image

Harold Miller discusses the opportunities to reduce spending on cancer care without harming patients

video-image

Harold Miller discusses the barriers in the fee for service model

video-image

Gary Palmer, MD, JD, MBA, discusses how NantWorks and NantHealth is involved in the Cancer Moonshot

video-image

Gary Palmer, MD, JD, MBA, tells us when the GPS Cancer test will be available